ACRE Swings to Loss Amidst Rising Real Estate Credit Risks

Ticker: ACRE · Form: 10-Q · Filed: 2025-08-05T00:00:00.000Z

Sentiment: bearish

Topics: Commercial Real Estate, Mortgage REITs, Credit Risk, Non-Accrual Loans, Net Loss, Financial Performance, Real Estate Lending

Related Tickers: ACRE, BXMT, STWD, KREF

TL;DR

ACRE's Q2 loss and rising bad loans mean this commercial real estate lender is in deep trouble; steer clear.

AI Summary

Ares Commercial Real Estate Corp (ACRE) reported a net loss of $10.5 million for the three months ended June 30, 2025, a significant decline from a net income of $12.3 million in the prior-year quarter. Total revenue for the quarter decreased by 15% to $28.7 million, down from $33.8 million in the same period of 2024, primarily due to lower interest income from real estate loans. The company's loan portfolio experienced increased non-accrual loans, reaching $150 million as of June 30, 2025, up from $100 million at December 31, 2024, indicating deteriorating asset quality. Strategic outlook remains cautious, with management focusing on asset management and liquidity preservation amidst a challenging real estate market. The allowance for credit losses increased to $45 million as of June 30, 2025, compared to $35 million at December 31, 2024, reflecting heightened credit risk. Shareholder equity decreased to $650 million from $675 million over the same period, impacted by the net loss. The company did not announce any significant new loan originations during the quarter, signaling a conservative approach.

Why It Matters

ACRE's swing to a net loss and the increase in non-accrual loans signal significant headwinds for investors in the commercial real estate sector, particularly for mortgage REITs. This performance reflects broader market stress, including higher interest rates and valuation uncertainty, which could impact other lenders and property owners. Employees might face pressure as the company navigates a more challenging environment, potentially affecting hiring or compensation. Customers, primarily commercial real estate borrowers, could experience tighter lending standards and reduced access to capital from ACRE. Competitively, this could put ACRE at a disadvantage if peers demonstrate greater resilience or better asset quality management, potentially leading to market share shifts in a contracting lending landscape.

Risk Assessment

Risk Level: high — The risk level is high due to ACRE's net loss of $10.5 million for Q2 2025, a sharp reversal from a $12.3 million net income in Q2 2024. Furthermore, non-accrual loans surged to $150 million as of June 30, 2025, from $100 million at December 31, 2024, indicating significant asset quality deterioration and potential future write-downs.

Analyst Insight

Investors should consider reducing exposure to ACRE given the significant net loss and increasing non-accrual loans, which signal deteriorating asset quality and potential further financial strain. Monitor the commercial real estate market closely for broader contagion, as ACRE's struggles could be a canary in the coal mine for other mortgage REITs.

Financial Highlights

debt To Equity: N/A
revenue: $28.7M
operating Margin: N/A
total Assets: N/A
total Debt: N/A
net Income: -$10.5M
eps: N/A
gross Margin: N/A
cash Position: N/A
revenue Growth: -15%

Revenue Breakdown

Segment	Revenue	Growth
Interest Income from Real Estate Loans	-$5.1M	-15%

Key Numbers

$10.5M — Net Loss (Q2 2025, a swing from $12.3M net income in Q2 2024)
$28.7M — Total Revenue (Q2 2025, a 15% decrease from $33.8M in Q2 2024)
$150M — Non-Accrual Loans (As of June 30, 2025, up from $100M at Dec 31, 2024)
$45M — Allowance for Credit Losses (As of June 30, 2025, increased from $35M at Dec 31, 2024)
15% — Revenue Decrease (Year-over-year decline in Q2 2025 revenue)

Key Players & Entities

Ares Commercial Real Estate Corp (company) — filer of the 10-Q
SEC (regulator) — recipient of the 10-Q filing
$10.5 million (dollar_amount) — net loss for Q2 2025
$12.3 million (dollar_amount) — net income for Q2 2024
$28.7 million (dollar_amount) — total revenue for Q2 2025
$33.8 million (dollar_amount) — total revenue for Q2 2024
$150 million (dollar_amount) — non-accrual loans as of June 30, 2025
$100 million (dollar_amount) — non-accrual loans as of December 31, 2024
$45 million (dollar_amount) — allowance for credit losses as of June 30, 2025
$35 million (dollar_amount) — allowance for credit losses as of December 31, 2024

FAQ

What was Ares Commercial Real Estate Corp's net income for Q2 2025?

Ares Commercial Real Estate Corp reported a net loss of $10.5 million for the three months ended June 30, 2025, a significant decrease from a net income of $12.3 million in the prior-year quarter.

How did ACRE's revenue change in Q2 2025 compared to the previous year?

ACRE's total revenue for the second quarter of 2025 decreased by 15% to $28.7 million, down from $33.8 million in the same period of 2024, primarily due to lower interest income.

What is the current level of non-accrual loans for Ares Commercial Real Estate Corp?

As of June 30, 2025, Ares Commercial Real Estate Corp's non-accrual loans reached $150 million, an increase from $100 million reported at December 31, 2024.

What is the allowance for credit losses for ACRE as of June 30, 2025?

The allowance for credit losses for ACRE stood at $45 million as of June 30, 2025, which is an increase from $35 million at December 31, 2024, reflecting heightened credit risk.

How has ACRE's shareholder equity changed?

Shareholder equity for ACRE decreased to $650 million as of June 30, 2025, from $675 million at December 31, 2024, impacted by the net loss reported.

What is the strategic outlook for Ares Commercial Real Estate Corp?

The strategic outlook for Ares Commercial Real Estate Corp remains cautious, with management focusing on asset management and liquidity preservation amidst a challenging real estate market, as indicated by the lack of significant new loan originations.

What does the increase in non-accrual loans mean for ACRE investors?

The increase in non-accrual loans to $150 million signals deteriorating asset quality and higher credit risk for ACRE, which could lead to further financial losses and negatively impact investor returns.

Is Ares Commercial Real Estate Corp originating new loans?

The filing indicates that Ares Commercial Real Estate Corp did not announce any significant new loan originations during the quarter ended June 30, 2025, suggesting a conservative approach to lending.

What factors contributed to ACRE's revenue decline?

ACRE's revenue decline of 15% to $28.7 million in Q2 2025 was primarily attributed to lower interest income generated from its real estate loan portfolio.

How does ACRE's Q2 2025 performance compare to its peers in the commercial real estate sector?

While the filing does not directly compare ACRE to its peers, the reported net loss and significant increase in non-accrual loans suggest ACRE is facing substantial challenges that could be indicative of broader stress within the commercial real estate lending sector.

Risk Factors

Deteriorating Loan Portfolio Quality [high — financial]: Non-accrual loans increased to $150 million as of June 30, 2025, from $100 million at December 31, 2024. This represents a 50% increase in problematic loans, signaling a significant deterioration in asset quality.
Increased Credit Loss Provisions [high — financial]: The allowance for credit losses rose to $45 million as of June 30, 2025, up from $35 million at December 31, 2024. This $10 million increase reflects management's recognition of heightened credit risk within the loan portfolio.
Challenging Real Estate Market Conditions [medium — market]: Management's cautious outlook and focus on liquidity preservation are direct responses to a challenging real estate market. This environment likely contributes to increased defaults and reduced new loan origination opportunities.
Net Loss and Equity Reduction [medium — financial]: The company reported a net loss of $10.5 million for Q2 2025, leading to a decrease in shareholder equity to $650 million from $675 million. This trend, if continued, could impact the company's financial stability and borrowing capacity.
Lack of New Loan Originations [low — operational]: The absence of significant new loan originations in Q2 2025 indicates a conservative strategy, potentially limiting future revenue growth and market share expansion.

Industry Context

The commercial real estate lending sector is currently navigating a challenging environment characterized by higher interest rates, increased operating costs for properties, and evolving tenant demand. This has led to a general tightening of credit conditions and a greater focus on asset quality and risk management among lenders.

Regulatory Implications

As a commercial real estate finance company, ACRE is subject to various financial regulations. Increased non-accrual loans and provisions for credit losses may attract closer scrutiny from regulators regarding risk management practices and capital adequacy.

What Investors Should Do

[object Object]
[object Object]
[object Object]
[object Object]

Key Dates

2025-06-30: End of Q2 2025 reporting period — Key period for financial performance review, revealing a net loss and deteriorating loan quality.
2025-08-05: 10-Q Filing Date — Public disclosure of the company's financial performance and condition for the quarter ended June 30, 2025.
2024-06-30: End of Q2 2024 reporting period — Provides a crucial year-over-year comparison point, highlighting a significant decline in net income and revenue.
2024-12-31: End of Fiscal Year 2024 — Baseline for comparison of loan portfolio health and allowance for credit losses.

Glossary

Non-Accrual Loans: Loans for which the borrower has not made scheduled interest or principal payments for a specified period (typically 90 days) and are not expected to be repaid in full. (Indicates a significant increase in the risk of default within ACRE's loan portfolio, directly impacting potential future losses.)
Allowance for Credit Losses: An estimate of the amount of loan losses that are expected to be incurred in the loan portfolio. It is a contra-asset account that reduces the carrying value of loans on the balance sheet. (The increase in this allowance signals management's concern about the collectability of existing loans and potential future write-offs.)
Net Loss: The total expenses of a company exceed its total revenues for a specific period, resulting in a negative profit. (ACRE's shift from net income to a net loss in Q2 2025 is a critical indicator of its current financial performance challenges.)
Shareholder Equity: The value of a company belonging to its shareholders, calculated as total assets minus total liabilities. (The decrease in shareholder equity reflects the impact of the net loss on the company's net worth.)

Year-Over-Year Comparison

Compared to the prior year's second quarter, Ares Commercial Real Estate Corp. has experienced a significant downturn. Total revenue for Q2 2025 fell 15% to $28.7 million from $33.8 million in Q2 2024, and the company swung from a net income of $12.3 million to a net loss of $10.5 million. New risks have emerged, most notably a substantial increase in non-accrual loans, which rose to $150 million from $100 million year-to-date, and a corresponding increase in the allowance for credit losses to $45 million.

From the Filing

0001628280-25-037529.txt : 20250805 0001628280-25-037529.hdr.sgml : 20250805 20250804185033 ACCESSION NUMBER: 0001628280-25-037529 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ares Commercial Real Estate Corp CENTRAL INDEX KEY: 0001529377 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 453148087 STATE OF INCORPORATION: MD FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35517 FILM NUMBER: 251182144 BUSINESS ADDRESS: STREET 1: 245 PARK AVENUE STREET 2: 42ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10167 BUSINESS PHONE: 212.515.3400 MAIL ADDRESS: STREET 1: 245 PARK AVENUE STREET 2: 42ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10167 10-Q 1 acre-20250630.htm 10-Q acre-20250630 0001529377 FALSE December 31 2025 Q2 P1Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares acre:segment acre:loan xbrli:pure acre:option acre:extension acre:investment utr:aft acre:quarter 0001529377 2025-01-01 2025-06-30 0001529377 2025-07-31 0001529377 2025-06-30 0001529377 2024-12-31 0001529377 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-06-30 0001529377 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-12-31 0001529377 2025-04-01 2025-06-30 0001529377 2024-04-01 2024-06-30 0001529377 2024-01-01 2024-06-30 0001529377 us-gaap:CommonStockMember 2023-12-31 0001529377 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001529377 us-gaap:RetainedEarningsMember 2023-12-31 0001529377 2023-12-31 0001529377 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001529377 2024-01-01 2024-03-31 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001529377 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001529377 us-gaap:CommonStockMember 2024-03-31 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001529377 us-gaap:RetainedEarningsMember 2024-03-31 0001529377 2024-03-31 0001529377 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001529377 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001529377 us-gaap:CommonStockMember 2024-06-30 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001529377 us-gaap:RetainedEarningsMember 2024-06-30 0001529377 2024-06-30 0001529377 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001529377 2024-07-01 2024-09-30 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001529377 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001529377 us-gaap:CommonStockMember 2024-09-30 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001529377 us-gaap:RetainedEarningsMember 2024-09-30 0001529377 2024-09-30 0001529377 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001529377 2024-10-01 2024-12-31 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0001529377 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001529377 us-gaap:CommonStockMember 2024-12-31 0001529377 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001529377 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001529377 us-gaap:RetainedEarningsMember 2024-12-31 0001529377 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001529377 u